These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9025832)

  • 1. Mitochondrial enlargement and crystalloid matrix arrays: distinctive finding in childhood portal hypertension due to cavernous transformation of the portal vein.
    Daugherty CC; Yazigi N; Bove K; Balistreri W
    Pediatr Pathol Lab Med; 1996; 16(2):263-74. PubMed ID: 9025832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.
    Abraham SC; Kamath PS; Eghtesad B; Demetris AJ; Krasinskas AM
    Am J Surg Pathol; 2006 Nov; 30(11):1454-61. PubMed ID: 17063088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cavernoma of the portal vein, a cause of portal hypertension in small children--apropos a clinical case].
    Creţu S; Bulucea D
    Rev Pediatr Obstet Ginecol Pediatr; 1985; 34(4):341-3. PubMed ID: 3938051
    [No Abstract]   [Full Text] [Related]  

  • 4. [Our experience in the management of portal cavernoma in children].
    Broto J; Infante D; Tormo R; Marhuenda C; Gil Vernet JM; Boix-Ochoa J
    Cir Pediatr; 1995 Jul; 8(3):99-101. PubMed ID: 8527323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology of noncirrhotic portal hypertension: clinicopathologic study in pediatric patients.
    Abramowsky C; Romero R; Heffron T
    Pediatr Dev Pathol; 2003; 6(5):421-6. PubMed ID: 14708735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatoportal sclerosis associated with portal vein thrombosis in children: report of 3 cases].
    Hessel G; Escanhoela CA; de Oliveira AD; De-Maria HK; Onishi E; Yamada RM; Ferreira AG
    Arq Gastroenterol; 1997; 34(2):121-5. PubMed ID: 9496428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An unusual case of cavernous portal vein transformation].
    Höhne U; Friedrich M; Kunath U
    Aktuelle Radiol; 1995 Mar; 5(2):109-11. PubMed ID: 7756360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatic involvment in cavernomas of the portal vein].
    Lemaigre G; Leger L
    Nouv Presse Med; 1973 Nov; 2(40):2651-3. PubMed ID: 4760673
    [No Abstract]   [Full Text] [Related]  

  • 9. Transjugular portosystemic shunt in chronic portal vein occlusion: importance of segmental portal hypertension in cavernous transformation of the portal vein.
    Walser EM; Soloway R; Raza SA; Gill A
    J Vasc Interv Radiol; 2006 Feb; 17(2 Pt 1):373-8. PubMed ID: 16517786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic portal cavernoma as an indication for liver transplantation.
    Hajdu CH; Murakami T; Diflo T; Taouli B; Laser J; Teperman L; Petrovic LM
    Liver Transpl; 2007 Sep; 13(9):1312-6. PubMed ID: 17763385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hydatid cyst in the hepatic hilum causing a cavernous transformation in the portal vein].
    Gil-Egea MJ; Alameda F; Girvent M; Riera R; Sitges-Serra A
    Gastroenterol Hepatol; 1998 May; 21(5):227-9. PubMed ID: 9644876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The septic abscess wall: a cytokine-generating organ associated with portal venous cytokinemia, hepatic outflow fibrosis, sinusoidal congestion, inflammatory cell sequestration, hepatocellular lipid deposition, and focal cell death.
    Ceydeli A; Condon MR; Siegel JH
    Shock; 2003 Jul; 20(1):74-84. PubMed ID: 12813373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopically disclosed findings of insidious portal hypertension in a hepatitis B surface antigen carrier.
    Iwamura K; Ohta W; Golebiowski M; Inaba R
    Tokai J Exp Clin Med; 1984 Oct; 9(4):275-84. PubMed ID: 6242204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cavernous transformation of the portal vein].
    Ukita M; Kawakami T; Kametani M; Futamura M
    Ryoikibetsu Shokogun Shirizu; 1995; (8):228-30. PubMed ID: 8581615
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical analysis of childhood cavernous transformation of the portal vein].
    Li Y; Li YH; Zhang LJ; Pan HM
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Feb; 8(1):75-6. PubMed ID: 16522248
    [No Abstract]   [Full Text] [Related]  

  • 17. Idiopathic portal hypertension and its pathology.
    Okudaira M; Ohbu M; Okuda K
    Semin Liver Dis; 2002 Feb; 22(1):59-72. PubMed ID: 11928079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic fibrosis associated with hereditary cystinosis: a novel form of noncirrhotic portal hypertension.
    Klenn PJ; Rubin R
    Mod Pathol; 1994 Oct; 7(8):879-82. PubMed ID: 7838843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic localization of endothelin-1 in patients with idiopathic portal hypertension and cirrhosis of the liver.
    Kamath PS; Carpenter HA; Lloyd RV; McKusick MA; Steers JL; Nagorney DM; Miller VM
    Liver Transpl; 2000 Sep; 6(5):596-602. PubMed ID: 10980059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrophy-hypertrophy complex in patients with cavernous transformation of the portal vein: CT evaluation.
    Vilgrain V; Condat B; Bureau C; Hakimé A; Plessier A; Cazals-Hatem D; Valla DC
    Radiology; 2006 Oct; 241(1):149-55. PubMed ID: 16908681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.